| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | $300.00K | $800.00K |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $2.83M | $585.61K | $614.69K | $746.27K | $526.98K |
| R&D | – | – | – | – | – |
| SG&A | $1.65M | $324.99K | $410.67K | $630.84K | $428.98K |
| Operating Income | -$2.83M | -$585.61K | -$614.69K | -$446.27K | $273.02K |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$2.83M | -$631.11K | -$817.23K | -$1.24M | -$566.80K |
| EPS (basic) | -0.0300 | -0.0100 | -0.0100 | -0.0200 | -0.0100 |
| EPS (diluted) | -0.0300 | -0.0100 | -0.0100 | -0.0200 | -0.0100 |
| Shares (diluted) | $82.03M | $62.55M | $60.86M | $60.86M | $60.38M |